{"id":"https://openalex.org/W1834894137","doi":null,"title":"Pharmacokinetics of tobramycin nebulizer solution (300mg/4ml) administered by Pari e-Flow rapid vs Pari LC plus nebulizer in patients with cystic fibrosis and Pseudomonas aeruginosa infection","display_name":"Pharmacokinetics of tobramycin nebulizer solution (300mg/4ml) administered by Pari e-Flow rapid vs Pari LC plus nebulizer in patients with cystic fibrosis and Pseudomonas aeruginosa infection","publication_year":2012,"publication_date":"2012-09-01","ids":{"openalex":"https://openalex.org/W1834894137","mag":"1834894137"},"language":"en","primary_location":{"id":"mag:1834894137","doi":null,"is_oa":false,"landing_page_url":"https://erj.ersjournals.com/content/erj/40/Suppl_56/P3377.full.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"European Respiratory Journal","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011256855","display_name":"Mirco Govoni","orcid":"https://orcid.org/0000-0002-7834-7237","observed_orcids":["https://orcid.org/0000-0002-7834-7237"]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mirco Govoni","raw_affiliation_strings":["Clinical Pharmacology, Chiesi Farmaceutici, Parma, Italy"],"raw_orcid":"https://orcid.org/0000-0002-7834-7237","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Chiesi Farmaceutici, Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070982242","display_name":"Gianluigi Poli","orcid":"https://orcid.org/0000-0002-3758-7664","observed_orcids":["https://orcid.org/0000-0002-3758-7664"]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gianluigi Poli","raw_affiliation_strings":["Clinical Pharmacology, Chiesi Farmaceutici, Parma, Italy"],"raw_orcid":"https://orcid.org/0000-0002-3758-7664","affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Chiesi Farmaceutici, Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030118395","display_name":"HELEN G. CICIRELLO","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Cicirello","raw_affiliation_strings":["Clinical Corporate Development, Chiesi Pharmaceuticals, Inc, Rockville, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Corporate Development, Chiesi Pharmaceuticals, Inc, Rockville, MD, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011676406","display_name":"Debora Santoro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Debora Santoro","raw_affiliation_strings":["Statistics & Data Management, Chiesi Farmaceutici, Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistics & Data Management, Chiesi Farmaceutici, Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023979944","display_name":"Daniela Acerbi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210162628","display_name":"Chiesi (Italy)","ror":"https://ror.org/0511bn634","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210162628"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Daniela Acerbi","raw_affiliation_strings":["Clinical Pharmacology, Chiesi Farmaceutici, Parma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Chiesi Farmaceutici, Parma, Italy","institution_ids":["https://openalex.org/I4210162628"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029140823","display_name":"Jozef Ru\u017ei\u010dka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jozef Ru\u017ei\u010dka","raw_affiliation_strings":["Dept of Pneumology, Fakultn\u00e1 Nemocnica's Poliklinikou, Bratislava, Slovakia (Slovak Republic)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Pneumology, Fakultn\u00e1 Nemocnica's Poliklinikou, Bratislava, Slovakia (Slovak Republic)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.12698332,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"40","issue":null,"first_page":"3377","last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.5170999765396118,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.5170999765396118,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.39649999141693115,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.07930000126361847,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cystic-fibrosis","display_name":"cystic fibrosis","score":0.7480000257492065},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa-infection","display_name":"Pseudomonas aeruginosa infection","score":0.9909999966621399},{"id":"https://openalex.org/keywords/nebulizer-comparison","display_name":"nebulizer comparison","score":0.8489999771118164},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8220000267028809},{"id":"https://openalex.org/keywords/pulmonary-drug-delivery","display_name":"pulmonary drug delivery","score":0.7630000114440918},{"id":"https://openalex.org/keywords/sputum-drug-concentration","display_name":"sputum drug concentration","score":0.7960000038146973},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.656000018119812},{"id":"https://openalex.org/keywords/inhalation-therapy","display_name":"inhalation therapy","score":0.5210000276565552},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7129999995231628},{"id":"https://openalex.org/keywords/aminoglycosides","display_name":"aminoglycosides","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C2780352487","wikidata":"https://www.wikidata.org/wiki/Q2281580","display_name":"Nebulizer","level":2,"score":0.9212508797645569},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.891727089881897},{"id":"https://openalex.org/C2778974779","wikidata":"https://www.wikidata.org/wiki/Q1758380","display_name":"Tobramycin","level":4,"score":0.8706107139587402},{"id":"https://openalex.org/C2776301714","wikidata":"https://www.wikidata.org/wiki/Q259346","display_name":"Sputum","level":3,"score":0.7443591952323914},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.728247880935669},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7145062685012817},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6503208875656128},{"id":"https://openalex.org/C40222840","wikidata":"https://www.wikidata.org/wiki/Q185049","display_name":"Geometric mean","level":2,"score":0.4523041546344757},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.43814817070961},{"id":"https://openalex.org/C2776954882","wikidata":"https://www.wikidata.org/wiki/Q840343","display_name":"Inhalation","level":2,"score":0.4348646104335785},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.42520570755004883},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.41572049260139465},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3289499282836914},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3186414837837219},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.06346958875656128},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1834894137","doi":null,"is_oa":false,"landing_page_url":"https://erj.ersjournals.com/content/erj/40/Suppl_56/P3377.full.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"European Respiratory Journal","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2048055596","https://openalex.org/W1984893629","https://openalex.org/W2007313191","https://openalex.org/W2170927479","https://openalex.org/W2080477062","https://openalex.org/W1995178326","https://openalex.org/W2581432333","https://openalex.org/W2607211926","https://openalex.org/W7213316988","https://openalex.org/W2220692989"],"abstract_inverted_index":{"Background:":[0],"New":[2],"generation":[3],"nebulizers":[4,251],"are":[5],"increasingly":[6],"used":[7],"to":[8,215],"reduce":[9],"the":[10,25,38,43,99,119,138,150,179,210,216,258],"time":[11,205,256],"required":[12],"for":[13,157,183,209,257],"inhalation,":[14],"potentially":[15],"improving":[16],"patient":[17],"compliance.":[18],"Objectives:":[21],"To":[23],"compare":[24],"pharmacokinetic":[26],"(PK)":[27],"profile":[28],"of":[29,242],"tobramycin":[30,110,159,185],"nebulizer":[31],"solution":[32],"(TNS)":[33],"300mg/4mL":[34,77],"(Bramitob\u00ae)":[35],"administered":[36],"with":[37,61,75,252],"Pari":[39,44,259],"e-Flow":[40,260],"rapid":[41,212],"versus":[42,220],"LC":[45,217],"plus":[46],"nebulizer.":[47],"Methods:":[50],"Randomized,":[52],"crossover":[53],"trial,":[54],"enrolling":[55],"27":[56,131],"cystic":[57],"fibrosis":[58],"(CF)":[59],"patients":[60,132,248],"chronic":[62],"Pseudomonas":[64],"aeruginosa":[65],"infection.":[67],"Patients":[68,140],"received":[69],"two":[70],"twice-daily,":[71],"28-day":[72],"treatment":[73],"periods":[74],"TNS":[76,243],"delivered":[78],"by":[79,83],"either":[80],"nebulizer,":[81],"separated":[82],"a":[84,253],"4-week":[85],"wash-out.":[86],"Blood":[87],"and":[88,96,102,116,135,163,172,189,198,234],"sputum":[89,184,235],"samples":[90],"were":[91,108,133,141,167,193],"collected":[92],"on":[93,124,226],"days":[94],"1":[95],"28":[97],"over":[98],"first":[100],"12":[101],"8":[103],"hours,":[104],"respectively.":[105,203],"Primary":[106],"endpoints":[107],"plasma":[109,158],"maximum":[111],"concentration":[112],"(C":[113],"max":[114,161,187],")":[115,123],"area":[117],"under":[118],"curve":[120],"(AUC":[121],"0-t":[122,165,191],"day":[125,227],"28.":[126],"Results:":[129],"randomized":[134],"25":[136],"completed":[137],"study.":[139],"18-47":[142],"(mean":[143,223],"25.5)":[144],"years":[145],"old.":[146],"On":[147],"Day":[148],"28,":[149],"geometric":[151,180],"mean":[152,181],"ratios":[153,182],"(e-Flow":[154],"rapid:LC":[155],"Plus)":[156],"C":[160,186],"AUC":[164,190],"0.85":[168],"(90%":[169,174,195,200],"CI":[170,175,196,201],"0.61-1.19)":[171],"0.87":[173],"0.65-1.18),":[176],"respectively,":[177],"while":[178],"1.40":[194],"0.86-2.27)":[197],"1.37":[199],"0.80-2.33),":[202],"Nebulization":[204],"was":[206],"significantly":[207],"shorter":[208,254],"eFlow":[211],"as":[213],"compared":[214],"plus:":[218],"5.7\u00b12.0":[219],"12.1\u00b12.2":[221],"min":[222],"\u00b1":[224],"SD":[225],"28).":[228],"Conclusion:":[231],"Plasma":[233],"PK":[236],"data":[237],"support":[238],"comparable":[239],"pulmonary":[240],"delivery":[241],"300":[244],"mg/4mL":[245],"in":[246],"CF":[247],"using":[249],"different":[250],"nebulization":[255],"device.":[261],"Supported":[263],"by:":[264],"Chiesi":[265],"Farmaceutici.":[266]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}